X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-03-03 | AKBA | Butler John P. | CEO, Pres | S - Sale | $1.83 | -46,409 | 2,877,777 | -2% | -$84,928 | ||||||
2025-03-03 | AKBA | Burke Steven Keith | SVP, Chief Medical Officer | S - Sale | $1.83 | -7,144 | 809,090 | -1% | -$13,074 | ||||||
| D | 2025-02-03 | AKBA | Butler John P. | CEO, Pres | S - Sale+OE | $2.10 | -144,250 | 2,924,186 | -5% | -$302,925 | |||||
| D | 2025-02-03 | AKBA | Burke Steven Keith | SVP, Chief Medical Officer | S - Sale+OE | $2.10 | -50,506 | 816,234 | -6% | -$106,063 | |||||
| D | 2025-02-03 | AKBA | Malabre Richard C | SVP, Chief Accounting Officer | S - Sale+OE | $2.10 | -30,202 | 280,248 | -10% | -$63,424 | |||||
| D | 2025-02-03 | AKBA | Grund Nicholas | Chief Commercial Officer | S - Sale+OE | $2.10 | -55,621 | 442,579 | -11% | -$116,804 | |||||
2024-05-13 | AKBA | Hadas Nicole R. | SVP, GC | S - Sale | $1.26 | -12,016 | 651,243 | -2% | -$15,140 | ||||||
2024-05-13 | AKBA | Dahan Michel | SVP, COO | S - Sale | $1.26 | -34,840 | 672,092 | -5% | -$43,898 | ||||||
2023-08-25 | AKBA | Burke Steven Keith | SVP, Chief Medical Officer | S - Sale | $1.15 | -27,000 | 668,840 | -4% | -$31,050 | ||||||
2024-02-29 | AKBA | Dahan Michel | SVP, COO | S - Sale | $1.58 | -8,661 | 706,932 | -1% | -$13,684 | ||||||
2024-02-29 | AKBA | Hadas Nicole R. | SVP, GC | S - Sale | $1.58 | -5,974 | 663,259 | -1% | -$9,439 | ||||||
2024-02-29 | AKBA | Butler John P. | CEO, Pres | S - Sale | $1.58 | -46,570 | 2,364,436 | -2% | -$73,581 | ||||||
2024-02-29 | AKBA | Burke Steven Keith | SVP, Chief Medical Officer | S - Sale | $1.58 | -7,169 | 695,840 | -1% | -$11,327 | ||||||
2024-02-27 | AKBA | Hadas Nicole R. | SVP, GC | S - Sale | $1.52 | -7,411 | 669,233 | -1% | -$11,265 | ||||||
2024-02-27 | AKBA | Dahan Michel | SVP, COO | S - Sale | $1.52 | -10,744 | 715,593 | -1% | -$16,331 | ||||||
2024-02-27 | AKBA | Burke Steven Keith | SVP, Chief Medical Officer | S - Sale | $1.52 | -8,367 | 703,009 | -1% | -$12,718 | ||||||
2024-02-27 | AKBA | Butler John P. | CEO, Pres | S - Sale | $1.52 | -37,733 | 2,411,006 | -2% | -$57,354 | ||||||
| D | 2024-02-01 | AKBA | Butler John P. | CEO, Pres | S - Sale+OE | $1.68 | -46,489 | 2,448,739 | -2% | -$78,102 | |||||
| D | 2024-02-01 | AKBA | Burke Steven Keith | SVP, Chief Medical Officer | S - Sale+OE | $1.68 | -24,311 | 711,376 | -3% | -$40,842 | |||||
| D | 2023-05-25 | AKBA | Hadas Nicole R. | SVP, GC | S - Sale+OE | $1.22 | -63,186 | 524,344 | -11% | -$77,270 | |||||
| D | 2023-05-25 | AKBA | Dahan Michel | SVP, COO | S - Sale+OE | $1.22 | -95,478 | 574,037 | -14% | -$116,760 | |||||
2023-05-16 | AKBA | Burke Steven Keith | SVP, Chief Medical Officer | S - Sale | $1.07 | -63,567 | 530,487 | -11% | -$67,890 | ||||||
2023-05-16 | AKBA | Spellman David A | SVP, CFO, Treasurer | S - Sale | $1.07 | -63,567 | 446,483 | -12% | -$67,890 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |